Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, April 08, 2026 (GLOBE NEWSWIRE) -- The "Hong Kong Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
-
WEST LAFAYETTE, Ind., April 08, 2026 (GLOBE NEWSWIRE) -- Professionals at federally qualified health centers, mental health centers, social service agencies, hospitals, institutes of higher...
-
Kam Pacific Co. Ltd. founder Fire launches Trader OS, an educational platform offering rule-based execution training for independent retail traders in HK.
-
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
AVITA Medical highlights new Cohealyx data and real-world evidence at upcoming ABA 2026, advancing wound healing and improving patient recovery outcomes
-
SINGAPUR, April 07, 2026 (GLOBE NEWSWIRE) -- Kingdom, una plataforma de sistemas de almacenamiento de energía en baterías ("BESS") establecida por Stonepeak, una firma líder de inversión alternativa...
-
SINGAPURA, April 07, 2026 (GLOBE NEWSWIRE) -- Kingdom, uma plataforma de sistema de armazenamento de energia de bateria ("BESS") criada pela Stonepeak, uma empresa líder em investimentos...
-
SINGAPURA, April 07, 2026 (GLOBE NEWSWIRE) -- Kingdom, sebuah platform sistem penyimpanan tenaga bateri ("BESS") yang ditubuhkan oleh Stonepeak, firma pelaburan alternatif terkemuka yang memfokuskan...
-
SINGAPURA, April 07, 2026 (GLOBE NEWSWIRE) -- Kingdom, platform sistem penyimpanan energi baterai (“BESS”) yang didirikan oleh Stonepeak, perusahaan investasi alternatif terkemuka dengan...
-
SINGAPOUR, 07 avr. 2026 (GLOBE NEWSWIRE) -- Kingdom, une plateforme de systèmes de stockage d’énergie par batteries (« BESS ») créée par Stonepeak, société d’investissement alternative de premier...
-
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SIM0505 for the treatment of women with platinum resistant ovarian cancer (PROC) Phase 1 data for SIM0505 to be...